Spotlight -

Drug Development|

Quality Systems

Kevin Smith (Cephalon)

is with Cephalon

Articles by Kevin Smith (Cephalon)

Implications and Opportunities of Applying QbD Principles to Analytical Measurement

ByKevin Smith (Cephalon),Matthias Pohl,Mark Schweitzer,Jaqueline Larew,Melissa Hanna-Brown,Gordon Hansen,Phil Nethercote,Phil Borman

February 1st 2010

Pharmaceutical Technology Europe

The authors present two concepts to improve robustness and facilitate continuous improvement in analytical methods.

Latest Updated Articles

Implications and Opportunities of Applying QbD Principles to Analytical Measurement
February 1st 2010

Trending on Pharmaceutical Technology

Pharma's AI ROI Problem Isn't a Tech Problem but a Qualification Problem

Inside Halo’s New Fill-Finish Platform

Alvelestat Deal Signals Early Manufacturing Push for AATD-LD

Q&A: AI Coding Tools Carry the Real Risk

BMS Bets on Flexible Capacity With $2.3B Texas Campus